{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:18Z","timestamp":1792701618311,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Early detection is considered to improve the prognosis of cutaneous melanoma. The value of population-based screening for melanoma, however, is still controversial. The aim of this study was to evaluate the predictive power of established risk factors in the setting of a population-based screening and to provide empirical evidence for potential risk stratifications. We reanalyzed data (including age, sex, risk factors, and screening results) of 354\u2009635 participants in the Skin Cancer Research to provide Evidence for Effectiveness of Screening in Northern Germany (SCREEN)project conducted in the German state of Schleswig-Holstein (2003\u20132004). In multivariable analysis, atypical nevi [odds ratio (OR): 17.4; 95% confidence interval (CI): 14.4\u201320.1], personal history of melanoma (OR: 5.3; 95% CI: 3.6\u20137.6), and multiple (\u226540) common nevi (OR: 1.3; 95% CI: 1.1\u20131.6) were associated with an increased risk of melanoma detection. Family history and congenital nevi were not significantly associated with melanoma detection in the SCREEN. The effects of several risk-adapted screening strategies were evaluated. Hypothesizing a screening of individuals aged more than or equal to 35 years, irrespective of risk factors (age approach), the number needed to screen is 559 (95% CI: 514\u2013612), whereas a screening of adults (aged \u226520) with at least one risk factor (risk approach) leads to a number needed to screen of 178 (95% CI: 163\u2013196). Converted into one screen-detected melanoma, the number of missed melanomas is 0.15 (95% CI: 0.12\u20130.18) with the age approach and 0.22 (95% CI: 0.19\u20130.26) with the risk approach. The results indicate that focusing on individuals at high risk for melanoma may improve the cost-effectiveness and the benefit-to-harm balance of melanoma screening programs.<\/jats:p>","DOI":"10.1097\/cej.0000000000000392","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T13:57:54Z","timestamp":1499435874000},"page":"563-569","source":"Crossref","is-referenced-by-count":24,"title":["Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening"],"prefix":"10.1097","volume":"27","author":[{"given":"Joachim","family":"H\u00fcbner","sequence":"first","affiliation":[{"name":"Institute of Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Institute of Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Eisemann","sequence":"additional","affiliation":[{"name":"Institute of Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Noftz","sequence":"additional","affiliation":[{"name":"Institute of Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Geller","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Center for Dermatoepidemiology, VA Medical Center Providence"},{"name":"Department of Dermatology, Rhode Island Hospital, Providence"},{"name":"Departments of Dermatology and Epidemiology, Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Volkmer","sequence":"additional","affiliation":[{"name":"Dermatology Center, Division of Molecular Cell Biology, Elbe Clinics Stade-Buxtehude, Buxtehude"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Greinert","sequence":"additional","affiliation":[{"name":"Dermatology Center, Division of Molecular Cell Biology, Elbe Clinics Stade-Buxtehude, Buxtehude"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard W.","family":"Breitbart","sequence":"additional","affiliation":[{"name":"Association of Dermatological Prevention e.V., Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[{"name":"Institute of Social Medicine and Epidemiology"},{"name":"Institute of Cancer Epidemiology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/eurpub\/cku047","article-title":"The German SCREEN project \u2013 design and evaluation of the communication strategy","volume":"25","author":"Anders","year":"2015","journal-title":"Eur J Public Health"},{"key":"R2-20230901","year":"2015"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"e008158","DOI":"10.1136\/bmjopen-2015-008158","article-title":"Melanoma mortality following skin cancer screening in Germany","volume":"5","author":"Boniol","year":"2015","journal-title":"BMJ Open"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch Dermatol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","article-title":"Systematic skin cancer screening in Northern Germany","volume":"66","author":"Breitbart","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaad.2016.07.045","article-title":"Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review","volume":"76","author":"Brunssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005a","journal-title":"Eur J Cancer"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005b","journal-title":"Eur J Cancer"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005c","journal-title":"Eur J Cancer"},{"key":"R10-20230901","first-page":"241","article-title":"Surveillance and follow-up examinations in cutaneous melanoma","volume":"26","author":"Garbe","year":"2003","journal-title":"Onkologie"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2012.06.013","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2012","volume":"48","author":"Garbe","year":"2012","journal-title":"Eur J Cancer"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/cncr.10855","article-title":"Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program","volume":"95","author":"Geller","year":"2002","journal-title":"Cancer"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/bjc.2016.390","article-title":"Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma","volume":"116","author":"H\u00fcbner","year":"2017","journal-title":"Br J Cancer"},{"key":"R15-20230901","first-page":"A","article-title":"Sonne, pigment und melanome","volume":"89","author":"Jung","year":"1992","journal-title":"Dtsch Arztebl"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1002\/cncr.27566","article-title":"Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening","volume":"118","author":"Katalinic","year":"2012","journal-title":"Cancer"},{"key":"R17-20230901","first-page":"629","article-title":"Skin cancer screening in Germany. documenting melanoma incidence and mortality from 2008 to 2013","volume":"112","author":"Katalinic","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07218.x","article-title":"Melanoma risk in congenital melanocytic naevi: a systematic review","volume":"155","author":"Krengel","year":"2006","journal-title":"Br J Dermatol"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/jid.2012.75","article-title":"Melanoma genetics: recent findings take us beyond well-traveled pathways","volume":"132","author":"Law","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R20-20230901","first-page":"611.e611","article-title":"Screening, early detection, education, and trends for melanoma: current status (2007\u20132013) and future directions: part II. Screening, education, and future directions","volume":"71","author":"Mayer","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1940-6207.CAPR-09-0108","article-title":"Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma","volume":"3","author":"Olsen","year":"2010a","journal-title":"Cancer Prev Res (Phila)"},{"key":"R22-20230901","first-page":"65","article-title":"Familial melanoma: a meta-analysis and estimates of attributable fraction. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive","volume":"19","author":"Olsen","year":"2010b","journal-title":"Oncology"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-14-210","article-title":"New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway","volume":"14","author":"Robsahm","year":"2014","journal-title":"BMC Cancer"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/cncr.20669","article-title":"Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study","volume":"101","author":"Rutter","year":"2004","journal-title":"Cancer"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2004.07.020","article-title":"Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management","volume":"52","author":"Tannous","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R26-20230901","first-page":"161","article-title":"Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82","volume":"68","author":"Tucker","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer: US Preventive Services Task Force Recommendation Statement","volume":"316","year":"2016","journal-title":"JAMA"},{"key":"R28-20230901","first-page":"1450","article-title":"Risk prediction models for melanoma: a systematic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive","volume":"23","author":"Usher-Smith","year":"2014","journal-title":"Oncology (Review)"},{"issue":"Suppl","key":"R29-20230901","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/CEJ.0000000000000142","article-title":"Future perspectives for cancer screening","volume":"24","author":"Viguier","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.0022-202x.2001.01415.x","article-title":"Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study","volume":"117","author":"Wachsmuth","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archdermatol.2012.893","article-title":"Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations","volume":"148","author":"Waldmann","year":"2012","journal-title":"Arch Dermatol"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bjd.13403","article-title":"Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review","volume":"172","author":"Watts","year":"2015","journal-title":"Br J Dermatol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201811000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:07:13Z","timestamp":1693613233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201811000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000392","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}